We are leveraging new technology to create virtuous cycles of learning around datasets to build a next-generation biopharmaceutical company.
People also ask
What does Recursion company do?
Is Recursion a good company?
How big is recursion company?
Is Recursion Pharmaceuticals a good stock to buy?
Jul 26, 2024 · We are a clinical-stage TechBio company decoding biology by integrating technological innovations across biology, chemistry, automation, data science and ...
CEO: Christopher Gibson (Nov 2013–)
Founders: Christopher Gibson, Blake Borgeson, and Dean Li
Headquarters: Salt Lake City, UT
Date founded: 2013
Location: Salt Lake City, Utah
Show more
Show less
Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery.
Recursion is the preeminent provider of analytic data tools in the mortgage industry.
Recursion Pharmaceuticals is creating an AI-enabled human biology map to accelerate discovery of treatments for rare, untreated diseases.
Aug 19, 2024 · Recursion will release proof-of-concept clinical trial data over the next 12 months; investor interest in seeing if AI can speed drug ...
In 2015, Li founded Recursion in New York, a Fintech company integrating technology, finance, and big data. In 5 years, Li turned Recursion into an ...